Conference: 27 – 29 January 2021

Location: Berlin, Germany / also Live Stream & On- Demand

Website: https://bit.ly/2FPoI56

With increased impact from the pandemic, pharma and biotech companies are under pressure to deliver results and adapt to new business realities with a fresh approach to PPM. Covid-19 and its aftermath have brought into focus the need to prioritize better and deliver results under increased budget constraints. Project selection and portfolio valuation are crucial tools for PPM managers to understand their competitive advantage, core portfolio values and market forecasts, and to align with their strategic corporate objectives.This unique conference will discuss how you can articulate your priorities better in a COVID-19 environment, and how to overcome increased reporting overload and drive a positive impact in your portfolio strategy. We will explore strategic modeling in times of uncertainty, and how to align R&D and Commercial with an integrated data strategy that takes advantage of AI and machine learning opportunities. By attending this event, you will learn how to do efficient scenario prediction to achieve the right risk-benefit balance in your portfolio, and how in the long run, you can adapt to the new normal with resilient portfolio performance informed by sound-decision making.

Attending this conference will enable you to:

  • Articulate your priorities better in a COVID-19 environment
  • Balance financial and scientific value to ensure project portfolio alignment with strategy and delivering results under increased volatility
  • Explore how to overcome increased reporting workload to drive positive impact in your portfolio strategy
  • Ensure strategic management and modelling in times of uncertainty
  • Align R&D and Commercial with an integrated data strategy
  • Explore how to manage capacities and prioritise between projects

Learn from Key Practical Case Studies

  • Roche discuss the role of analytics in sound decision-making
  • LEO Pharma discuss the intedependency between portfolio leadership and management for effective decision-making
  • Ipsen explore project management maturity and performance
  • Bayer reflect on the importance of strategic management and modelling in times of heightened uncertainty
  • MSD explore the use of Data Sciences for better, more connected R&D insights


For details and to register, visit the website at
https://bit.ly/2FPoI56